On the other hand, LOX appears to act as a tumor suppressor in human osteosarcoma and NPC cell lines [22, 23], and decreased LOX activity was noted in fibrosarcoma, rhabdomyosarcoma and choriocarcinoma cell lines [20]. The gene discussed is LOX; the disease is nasopharyngeal carcinoma.